Medical Care
Global Gene Therapy For Heart Failure Market Research Report 2025
- Jul 08, 25
- ID: 347629
- Pages: 72
- Figures: 71
- Views: 1
The global market for Gene Therapy For Heart Failure was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Heart Failure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Heart Failure.
The Gene Therapy For Heart Failure market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy For Heart Failure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy For Heart Failure companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Askbio
RENOVACORINC
Uniqure
DINAQOR
PRECIGEN
Heartseed
Cardior
NOVARTIS
Blue Rock
Segment by Type
Gene Modification
Gene Replacement
Others
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Heart Failure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Heart Failure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Heart Failure.
The Gene Therapy For Heart Failure market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy For Heart Failure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy For Heart Failure companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Askbio
RENOVACORINC
Uniqure
DINAQOR
PRECIGEN
Heartseed
Cardior
NOVARTIS
Blue Rock
Segment by Type
Gene Modification
Gene Replacement
Others
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Heart Failure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Modification
1.2.3 Gene Replacement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Therapy For Heart Failure Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy For Heart Failure Market Perspective (2020-2031)
2.2 Global Gene Therapy For Heart Failure Growth Trends by Region
2.2.1 Global Gene Therapy For Heart Failure Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy For Heart Failure Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy For Heart Failure Market Dynamics
2.3.1 Gene Therapy For Heart Failure Industry Trends
2.3.2 Gene Therapy For Heart Failure Market Drivers
2.3.3 Gene Therapy For Heart Failure Market Challenges
2.3.4 Gene Therapy For Heart Failure Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy For Heart Failure Players by Revenue
3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy For Heart Failure Revenue
3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio
3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2024
3.5 Global Key Players of Gene Therapy For Heart Failure Head office and Area Served
3.6 Global Key Players of Gene Therapy For Heart Failure, Product and Application
3.7 Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy For Heart Failure Breakdown Data by Type
4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031)
5 Gene Therapy For Heart Failure Breakdown Data by Application
5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy For Heart Failure Market Size (2020-2031)
6.2 North America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy For Heart Failure Market Size by Country (2020-2025)
6.4 North America Gene Therapy For Heart Failure Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy For Heart Failure Market Size (2020-2031)
7.2 Europe Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025)
7.4 Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy For Heart Failure Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy For Heart Failure Market Size (2020-2031)
9.2 Latin America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Askbio
11.1.1 Askbio Company Details
11.1.2 Askbio Business Overview
11.1.3 Askbio Gene Therapy For Heart Failure Introduction
11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.1.5 Askbio Recent Development
11.2 RENOVACORINC
11.2.1 RENOVACORINC Company Details
11.2.2 RENOVACORINC Business Overview
11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction
11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.2.5 RENOVACORINC Recent Development
11.3 Uniqure
11.3.1 Uniqure Company Details
11.3.2 Uniqure Business Overview
11.3.3 Uniqure Gene Therapy For Heart Failure Introduction
11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.3.5 Uniqure Recent Development
11.4 DINAQOR
11.4.1 DINAQOR Company Details
11.4.2 DINAQOR Business Overview
11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction
11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.4.5 DINAQOR Recent Development
11.5 PRECIGEN
11.5.1 PRECIGEN Company Details
11.5.2 PRECIGEN Business Overview
11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction
11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.5.5 PRECIGEN Recent Development
11.6 Heartseed
11.6.1 Heartseed Company Details
11.6.2 Heartseed Business Overview
11.6.3 Heartseed Gene Therapy For Heart Failure Introduction
11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.6.5 Heartseed Recent Development
11.7 Cardior
11.7.1 Cardior Company Details
11.7.2 Cardior Business Overview
11.7.3 Cardior Gene Therapy For Heart Failure Introduction
11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.7.5 Cardior Recent Development
11.8 NOVARTIS
11.8.1 NOVARTIS Company Details
11.8.2 NOVARTIS Business Overview
11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction
11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.8.5 NOVARTIS Recent Development
11.9 Blue Rock
11.9.1 Blue Rock Company Details
11.9.2 Blue Rock Business Overview
11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction
11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.9.5 Blue Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Modification
1.2.3 Gene Replacement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Therapy For Heart Failure Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy For Heart Failure Market Perspective (2020-2031)
2.2 Global Gene Therapy For Heart Failure Growth Trends by Region
2.2.1 Global Gene Therapy For Heart Failure Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy For Heart Failure Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy For Heart Failure Market Dynamics
2.3.1 Gene Therapy For Heart Failure Industry Trends
2.3.2 Gene Therapy For Heart Failure Market Drivers
2.3.3 Gene Therapy For Heart Failure Market Challenges
2.3.4 Gene Therapy For Heart Failure Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy For Heart Failure Players by Revenue
3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy For Heart Failure Revenue
3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio
3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2024
3.5 Global Key Players of Gene Therapy For Heart Failure Head office and Area Served
3.6 Global Key Players of Gene Therapy For Heart Failure, Product and Application
3.7 Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy For Heart Failure Breakdown Data by Type
4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031)
5 Gene Therapy For Heart Failure Breakdown Data by Application
5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy For Heart Failure Market Size (2020-2031)
6.2 North America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy For Heart Failure Market Size by Country (2020-2025)
6.4 North America Gene Therapy For Heart Failure Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy For Heart Failure Market Size (2020-2031)
7.2 Europe Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025)
7.4 Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy For Heart Failure Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy For Heart Failure Market Size (2020-2031)
9.2 Latin America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Askbio
11.1.1 Askbio Company Details
11.1.2 Askbio Business Overview
11.1.3 Askbio Gene Therapy For Heart Failure Introduction
11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.1.5 Askbio Recent Development
11.2 RENOVACORINC
11.2.1 RENOVACORINC Company Details
11.2.2 RENOVACORINC Business Overview
11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction
11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.2.5 RENOVACORINC Recent Development
11.3 Uniqure
11.3.1 Uniqure Company Details
11.3.2 Uniqure Business Overview
11.3.3 Uniqure Gene Therapy For Heart Failure Introduction
11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.3.5 Uniqure Recent Development
11.4 DINAQOR
11.4.1 DINAQOR Company Details
11.4.2 DINAQOR Business Overview
11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction
11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.4.5 DINAQOR Recent Development
11.5 PRECIGEN
11.5.1 PRECIGEN Company Details
11.5.2 PRECIGEN Business Overview
11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction
11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.5.5 PRECIGEN Recent Development
11.6 Heartseed
11.6.1 Heartseed Company Details
11.6.2 Heartseed Business Overview
11.6.3 Heartseed Gene Therapy For Heart Failure Introduction
11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.6.5 Heartseed Recent Development
11.7 Cardior
11.7.1 Cardior Company Details
11.7.2 Cardior Business Overview
11.7.3 Cardior Gene Therapy For Heart Failure Introduction
11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.7.5 Cardior Recent Development
11.8 NOVARTIS
11.8.1 NOVARTIS Company Details
11.8.2 NOVARTIS Business Overview
11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction
11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.8.5 NOVARTIS Recent Development
11.9 Blue Rock
11.9.1 Blue Rock Company Details
11.9.2 Blue Rock Business Overview
11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction
11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025)
11.9.5 Blue Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Modification
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Others
Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy For Heart Failure Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Gene Therapy For Heart Failure Market Share by Region (2020-2025)
Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Gene Therapy For Heart Failure Market Share by Region (2026-2031)
Table 11. Gene Therapy For Heart Failure Market Trends
Table 12. Gene Therapy For Heart Failure Market Drivers
Table 13. Gene Therapy For Heart Failure Market Challenges
Table 14. Gene Therapy For Heart Failure Market Restraints
Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2020-2025)
Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)
Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Gene Therapy For Heart Failure, Headquarters and Area Served
Table 21. Global Key Players of Gene Therapy For Heart Failure, Product and Application
Table 22. Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2020-2025)
Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2026-2031)
Table 28. Global Gene Therapy For Heart Failure Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2020-2025)
Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2026-2031)
Table 32. North America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Gene Therapy For Heart Failure Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 47. Askbio Company Details
Table 48. Askbio Business Overview
Table 49. Askbio Gene Therapy For Heart Failure Product
Table 50. Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 51. Askbio Recent Development
Table 52. RENOVACORINC Company Details
Table 53. RENOVACORINC Business Overview
Table 54. RENOVACORINC Gene Therapy For Heart Failure Product
Table 55. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 56. RENOVACORINC Recent Development
Table 57. Uniqure Company Details
Table 58. Uniqure Business Overview
Table 59. Uniqure Gene Therapy For Heart Failure Product
Table 60. Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 61. Uniqure Recent Development
Table 62. DINAQOR Company Details
Table 63. DINAQOR Business Overview
Table 64. DINAQOR Gene Therapy For Heart Failure Product
Table 65. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 66. DINAQOR Recent Development
Table 67. PRECIGEN Company Details
Table 68. PRECIGEN Business Overview
Table 69. PRECIGEN Gene Therapy For Heart Failure Product
Table 70. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 71. PRECIGEN Recent Development
Table 72. Heartseed Company Details
Table 73. Heartseed Business Overview
Table 74. Heartseed Gene Therapy For Heart Failure Product
Table 75. Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 76. Heartseed Recent Development
Table 77. Cardior Company Details
Table 78. Cardior Business Overview
Table 79. Cardior Gene Therapy For Heart Failure Product
Table 80. Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 81. Cardior Recent Development
Table 82. NOVARTIS Company Details
Table 83. NOVARTIS Business Overview
Table 84. NOVARTIS Gene Therapy For Heart Failure Product
Table 85. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 86. NOVARTIS Recent Development
Table 87. Blue Rock Company Details
Table 88. Blue Rock Business Overview
Table 89. Blue Rock Gene Therapy For Heart Failure Product
Table 90. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 91. Blue Rock Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Gene Therapy For Heart Failure Picture
Figure 2. Global Gene Therapy For Heart Failure Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy For Heart Failure Market Share by Type: 2024 VS 2031
Figure 4. Gene Modification Features
Figure 5. Gene Replacement Features
Figure 6. Others Features
Figure 7. Global Gene Therapy For Heart Failure Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Gene Therapy For Heart Failure Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapy For Heart Failure Report Years Considered
Figure 13. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Gene Therapy For Heart Failure Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Therapy For Heart Failure Market Share by Region: 2024 VS 2031
Figure 16. Global Gene Therapy For Heart Failure Market Share by Players in 2024
Figure 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2024
Figure 19. North America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 21. United States Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 25. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2020-2031)
Figure 33. China Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 41. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 45. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 49. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 50. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 51. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 52. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 53. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 54. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 55. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 56. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Modification
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Others
Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy For Heart Failure Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Gene Therapy For Heart Failure Market Share by Region (2020-2025)
Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Gene Therapy For Heart Failure Market Share by Region (2026-2031)
Table 11. Gene Therapy For Heart Failure Market Trends
Table 12. Gene Therapy For Heart Failure Market Drivers
Table 13. Gene Therapy For Heart Failure Market Challenges
Table 14. Gene Therapy For Heart Failure Market Restraints
Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2020-2025)
Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)
Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Gene Therapy For Heart Failure, Headquarters and Area Served
Table 21. Global Key Players of Gene Therapy For Heart Failure, Product and Application
Table 22. Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2020-2025)
Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2026-2031)
Table 28. Global Gene Therapy For Heart Failure Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2020-2025)
Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2026-2031)
Table 32. North America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Gene Therapy For Heart Failure Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)
Table 47. Askbio Company Details
Table 48. Askbio Business Overview
Table 49. Askbio Gene Therapy For Heart Failure Product
Table 50. Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 51. Askbio Recent Development
Table 52. RENOVACORINC Company Details
Table 53. RENOVACORINC Business Overview
Table 54. RENOVACORINC Gene Therapy For Heart Failure Product
Table 55. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 56. RENOVACORINC Recent Development
Table 57. Uniqure Company Details
Table 58. Uniqure Business Overview
Table 59. Uniqure Gene Therapy For Heart Failure Product
Table 60. Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 61. Uniqure Recent Development
Table 62. DINAQOR Company Details
Table 63. DINAQOR Business Overview
Table 64. DINAQOR Gene Therapy For Heart Failure Product
Table 65. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 66. DINAQOR Recent Development
Table 67. PRECIGEN Company Details
Table 68. PRECIGEN Business Overview
Table 69. PRECIGEN Gene Therapy For Heart Failure Product
Table 70. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 71. PRECIGEN Recent Development
Table 72. Heartseed Company Details
Table 73. Heartseed Business Overview
Table 74. Heartseed Gene Therapy For Heart Failure Product
Table 75. Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 76. Heartseed Recent Development
Table 77. Cardior Company Details
Table 78. Cardior Business Overview
Table 79. Cardior Gene Therapy For Heart Failure Product
Table 80. Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 81. Cardior Recent Development
Table 82. NOVARTIS Company Details
Table 83. NOVARTIS Business Overview
Table 84. NOVARTIS Gene Therapy For Heart Failure Product
Table 85. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 86. NOVARTIS Recent Development
Table 87. Blue Rock Company Details
Table 88. Blue Rock Business Overview
Table 89. Blue Rock Gene Therapy For Heart Failure Product
Table 90. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)
Table 91. Blue Rock Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Gene Therapy For Heart Failure Picture
Figure 2. Global Gene Therapy For Heart Failure Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy For Heart Failure Market Share by Type: 2024 VS 2031
Figure 4. Gene Modification Features
Figure 5. Gene Replacement Features
Figure 6. Others Features
Figure 7. Global Gene Therapy For Heart Failure Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Gene Therapy For Heart Failure Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapy For Heart Failure Report Years Considered
Figure 13. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Gene Therapy For Heart Failure Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Therapy For Heart Failure Market Share by Region: 2024 VS 2031
Figure 16. Global Gene Therapy For Heart Failure Market Share by Players in 2024
Figure 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2024
Figure 19. North America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 21. United States Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 25. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2020-2031)
Figure 33. China Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 41. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2020-2031)
Figure 45. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 49. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 50. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 51. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 52. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 53. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 54. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 55. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 56. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232